ArticleClinical research in cardiology : official journal of the German Cardiac Society2025
Prognostic value of high-sensitivity cardiac troponin I after isolated non-CABG cardiac surgery.
Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the prognostic value of peak postoperative high-sensitivity cardiac troponin I (hs-cTnI) in patients undergoing cardiac valvular (CV) or thoracic aortic (TA) surgery without concomitant coronary artery bypass grafting (CABG).
methodsWe analyzed data from a prospective, single-center registry of adult patients (≥ 18 years) who underwent elective, isolated CV or TA surgery at a tertiary hospital in Germany between January 2013 and May 2019. Hs-cTnI levels were measured preoperatively and postoperatively at regular intervals up to 48 h. The associations between peak hs-cTnI and long-term and 30-day all-cause mortality were assessed using Cox proportional hazards models with regression splines, adjusted for baseline risk via EuroSCORE II.
resultsAmong 4232 patients (median age 69 years [IQR 59-76]; 38.4% female), 30-day all-cause mortality occurred in 61 patients (1.4%). Over a median follow-up of 3.1 years [IQR 1.9-5.0], 499 patients (11.8%) died. Peak hs-cTnI thresholds of 282 × the upper limit of normal (ULN) and 194 × ULN were associated with increased risk of long-term (HR 1.11, 95% CI 1.00-1.24) and 30-day mortality (hazard ratio (HR) 1.25, 95% CI 1.01-1.55), respectively. However, predictive performance was limited with area under the receiver operating curve (AUC) values of 0.56 for long-term mortality and 0.55 for 30-day mortality. Sensitivity and specificity were 41% and 71% for long-term mortality, and 54% and 55% for 30-day all-cause mortality. Negative predictive values remained high (both at 90%), but negative predictive values were low at 16% and 14%, respectively. When applying the sex-specific reference levels (16 pg/ml for women, 34 pg/ml for men), thresholds of 223 × ULN and 194 × ULN were identified for long-term and 30-day mortality, with corresponding HRs of 1.08 and 1.62 and AUCs of 0.58 and 0.57, respectively.
conclusionPeak hs-cTnI levels are independently associated with adverse outcomes following CV or TA surgery without CABG. However, effective risk discrimination is poor, and the identified thresholds far exceed conventional definitions of myocardial infarction. These findings support the need for surgery-specific hs-cTnI thresholds to improve perioperative risk stratification.
Indexed as
Identifiers
41143899What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.